Montvale, NJNCT03334708Now EnrollingIRB Ready

Pancreatic Cancer Clinical Trial in Montvale, NJ

Access cutting-edge pancreatic cancer treatment through this clinical trial at a research site in Montvale. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Montvale location

Preparing your pre-screening questions…

Expert Care in Montvale

Access pancreatic cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pancreatic cancer treatment provided free

Apply for This Montvale Location

Check if you qualify for this pancreatic cancer clinical trial in Montvale, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Montvale

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Montvale site if eligible
  4. 4Begin participation

About This Pancreatic Cancer Study in Montvale

The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Cohort 1: Advanced Pancreatic Cancer Cohort Inclusion Criteria
Radiological, histological or cytological confirmed diagnosis of locally advanced or metastatic pancreatic adenocarcinoma by the enrolling institution
Patient planning to receive systemic treatment
Hemoglobin \> 8
ECOG performance status 0-2
A minimum age of 18 years old
Willing to undergo a tumor biopsy
Willing to provide permission to obtain banked tumor tissue for analysis (previous biopsies or surgical material). Cohort 2: Operable Pancreatic Cancer Cohort Inclusion Criteria
Radiological, histological or cytological confirmed diagnosis of pancreatic adenocarcinoma by the enrolling institution
Patient planned to undergo upfront resection
No pre-operative systemic therapy nor chemoradiation therapy planned
Hemoglobin \> 8
ECOG performance status 0-2
A minimum age of 18 years old
Willing to undergo a tumor biopsy
Willing to provide permission to obtain banked tumor tissue for analysis (previous biopsies or surgical material). Cohort 3: Acute Benign Pancreatic Pathology Control Inclusion Criteria
Confirmed diagnosis of acute pancreatitis or other acute pancreatic pathology by the enrolling institution
Hemoglobin \> 8
ECOG performance status 0-2
A minimum age of 18 years old Cohort 4: Chronic Benign Pancreatic Pathology Control Inclusion Criteria
Confirmed diagnosis of chronic pancreatitis or other non-cystic chronic pancreatic pathology by the enrolling institution
Hemoglobin \> 8
ECOG performance status 0-2
A minimum age of 18 years old Cohort 5: IPMN Control Inclusion Criteria
Confirmed diagnosis of IPMN without high risk features by the enrolling institution
A minimum age of 18 years old Cohort 6: Pancreatic Cyst Control Inclusion Criteria
Confirmed diagnosis of benign pancreatic cyst by the enrolling institution
A minimum age of 18 years old Cohort 7: Healthy Control Inclusion Criteria
A minimum age of 18 years old

Exclusion Criteria

Cohort 1: Advanced Pancreatic Cancer Cohort Exclusion Criteria
Prior chemotherapy or radiation therapy for pancreatic cancer within the last 3 months in the localized setting
Active second malignancy, unless low grade malignancy
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures Cohort 2: Operable Pancreatic Cancer Cohort Exclusion Criteria
Neoadjuvant chemotherapy or radiation therapy is planned
Active second malignancy, unless low grade malignancy
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures Cohort 3: Acute Benign Pancreatic Pathology Control Exclusion Criteria
Active or prior malignancy, except prior non-melanoma skin cancer
Proven to be a carrier of a cancer susceptibility gene or family history concerning for genetic predisposition to cancer
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures Cohort 4: Chronic Benign Pancreatic Pathology Control Exclusion Criteria
Active or prior malignancy, except prior non-melanoma skin cancer
Proven to be a carrier of a cancer susceptibility gene or family history concerning for genetic predisposition to cancer
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures Cohort 5: IPMN Control Exclusion Criteria
IPMN with high risk features or planned resection
Active or prior malignancy, except prior non-melanoma skin cancer
Proven to be a carrier of a cancer susceptibility gene or family history concerning for genetic predisposition to cancer
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures Cohort 6: Pancreatic Cyst Control Exclusion Criteria
Active or prior malignancy, except prior non-melanoma skin cancer
Proven to be a carrier of a cancer susceptibility gene or family history concerning for genetic predisposition to cancer
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures Cohort 7: Healthy Control Exclusion Criteria
Active or prior malignancy, except prior non-melanoma skin cancer
Proven to be a carrier of a cancer susceptibility gene or family history concerning for genetic predisposition to cancer
Any medical or psychiatric condition that may interfere with ability to comply with protocol procedures

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Montvale?

Yes, this clinical trial (NCT03334708) has an active research site in Montvale, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pancreatic Cancer Treatment Options in Montvale, NJ

If you're searching for pancreatic cancer treatment options in Montvale, NJ, this clinical trial (NCT03334708) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Montvale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pancreatic cancer clinical trials near you to find additional studies recruiting in your area.

More Pancreatic Cancer Trials in Montvale, NJ

See all pancreatic cancer clinical trials recruiting in Montvale — not just this study.

Browse Pancreatic Cancer Trials in Montvale

Ready to Join in Montvale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Montvale, NJ